Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid, R.N. Foley, J.S. Gill, D.T. Gilbertson, A.J. Collins Kidney International Volume 71, Issue 5, Pages 425-430 (March 2007) DOI: 10.1038/sj.ki.5002056 Copyright © 2007 International Society of Nephrology Terms and Conditions
Figure 1 Mean hemoglobin levels, dialysis months 1–6. P<0.001 for each month for the comparison of patients with and without failed transplants. Hb, hemoglobin, in g/dl. Kidney International 2007 71, 425-430DOI: (10.1038/sj.ki.5002056) Copyright © 2007 International Society of Nephrology Terms and Conditions
Figure 2 Epoetin doses, dialysis months 1–6. P<0.001 for each month for the comparison of patients with and without failed transplants. Kidney International 2007 71, 425-430DOI: (10.1038/sj.ki.5002056) Copyright © 2007 International Society of Nephrology Terms and Conditions